/Solventum%20Corp%20logo%20on%20phone-by%20Below%20the%20Sky%20via%20Shutterstock.jpg)
Solventum Corporation (SOLV), based in Maplewood, Minnesota, is a healthcare company that develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs. With a market cap of $12.5 billion, the company’s broad portfolio of solutions leverages material and data science, clinical research, and digital capabilities. Solventum operates in separation and purification, health information, medical solutions, medical device components, and the oral care market. The leading global healthcare company is expected to announce its fiscal third-quarter earnings for 2025 after the market closes on Thursday, Nov. 6.
Ahead of the event, analysts expect SOLV to report a profit of $1.42 per share on a diluted basis, up 23.5% from $1.15 per share in the year-ago quarter. The company beat the consensus estimates in three of the last four quarters while missing the forecast on another occasion.